The SARS-CoV S glycoprotein.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 15526150)

Published in Cell Mol Life Sci on October 01, 2004

Authors

X Xiao1, D S Dimitrov

Author Affiliations

1: Protein Interactions Group, LECB, CCR, NCI-Frederick, NIH, Building 469, Room 105, Frederick, Maryland 21702-1201, USA.

Articles by these authors

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A (1999) 5.25

Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science (1996) 4.39

Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med (2001) 3.05

Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy. Lancet (2001) 2.31

Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A (2000) 2.20

Sensitive method for measuring telomere lengths by quantifying telomeric DNA content of whole cells. Biotechniques (1998) 2.10

The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s). Virology (1993) 2.05

Constitutive cell surface association between CD4 and CCR5. Proc Natl Acad Sci U S A (1999) 1.88

Ongoing HIV dissemination during HAART. Nat Med (1999) 1.85

An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences. J Virol (1994) 1.81

Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood (1997) 1.73

Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus. J Virol (2000) 1.73

Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5. J Virol (2000) 1.67

Membrane stability. Biochim Biophys Acta (1984) 1.36

N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates. J Virol (2000) 1.32

Electric field-induced breakdown of lipid bilayers and cell membranes: a thin viscoelastic film model. J Membr Biol (1984) 1.26

HIV and the 7-transmembrane domain receptors. Pathobiology (1996) 1.14

Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules. J Virol (1995) 1.07

HIV results in the frame. CD4+ cell turnover. Nature (1995) 1.03

Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes. J Biol Chem (2001) 0.99

The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells. J Virol (1994) 0.98

Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes. Blood (2000) 0.98

A fluid mechanical analysis of the velocity, adhesion, and destruction of cancer cells in capillaries during metastasis. Cell Biophys (1984) 0.96

Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time. J Virol (1993) 0.95

Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies. J Virol (1995) 0.94

Long-term telomere dynamics: modest increase of cell turnover in HIV-infected individuals followed for up to 14 years. Pathobiology (1999) 0.93

Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody. J Virol (1997) 0.93

Characterization of influenza virus-induced death of J774.1 macrophages. Exp Cell Res (1997) 0.90

Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion. Exp Mol Pathol (2000) 0.89

Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells. Exp Mol Pathol (2000) 0.86

Telomere dynamics in monkeys: increased cell turnover in macaques infected with chimeric simian-human immunodeficiency viruses. J Med Primatol (1999) 0.85

The hemodynamic destruction of intravascular cancer cells in relation to myocardial metastasis. Proc Natl Acad Sci U S A (1985) 0.85

Individual prognoses of long-term responses to antiretroviral treatment based on virological, immunological and pharmacological parameters measured during the first week under therapy. AIDS (1998) 0.84

Fusion of Mycoplasma fermentans strain incognitus with T-lymphocytes. FEBS Lett (1992) 0.84

Identification and characterization of rapidly dividing U937 clones with differential telomerase activity and gene expression profiles: role of c-Myc/Mad1 and Id/Ets proteins. Leukemia (2002) 0.83

Telomere dynamics in HIV-1 infected and uninfected chimpanzees measured by an improved method based on high-resolution two-dimensional calibration of DNA sizes. J Med Primatol (1998) 0.83

Mechanical aspects of the lungs as cancer cell-killing organs during hematogenous metastasis. J Theor Biol (1986) 0.82

Interactions of CD4+ plasma membrane vesicles with HIV-1 and HIV-1 envelope glycoprotein-expressing cells. J Acquir Immune Defic Syndr (1992) 0.81

LFA-1 adhesion molecules are not involved in the early stages of HIV-1 env-mediated cell membrane fusion. AIDS Res Hum Retroviruses (1992) 0.81

Increased association of glycoprotein 120-CD4 with HIV type 1 coreceptors in the presence of complex-enhanced anti-CD4 monoclonal antibodies. AIDS Res Hum Retroviruses (1999) 0.80

Stability of membrane systems modeled as multilayered viscoelastic films. J Theor Biol (1985) 0.79

Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo. J Immunol (1993) 0.79

Kinetics of HIV-1 RNA concentration changes in pediatric patients. Pathobiology (1996) 0.79

Red blood cell dielectrophoresis in axisymmetric fields. Cell Biophys (1986) 0.79

A trans-dominant mutation in human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp41 inhibits membrane fusion when expressed in target cells. Mol Membr Biol (1995) 0.78

Dicloxacillin pharmacokinetics in dogs after intravenous, intramuscular and oral administration. J Vet Pharmacol Ther (1998) 0.78

HIV-1 infection kinetics in tissue cultures. Math Biosci (1996) 0.78

The limit of PCR amplification. J Theor Biol (1996) 0.78

Dextran sulfate inhibits fusion of influenza virus and cells expressing influenza hemagglutinin with red blood cells. Biochim Biophys Acta (1992) 0.77

A hydrodynamic theory of bilayer membrane formation. Biophys J (1981) 0.76

Transcriptomic response to differentiation induction. BMC Bioinformatics (2006) 0.75

[Histological characteristics of the intraorbital glands of pheasants with tuberculosis]. Vet Med Nauki (1987) 0.75

Surface pressure hysteresis of mixed lipid/protein monolayers: applications to the alveolar dynamics. Z Naturforsch C (1985) 0.75

Electrofusion of fragile mutants of Saccharomyces cerevisiae. FEMS Microbiol Lett (1989) 0.75

Dynamics of viscoelastic spherical membranes- the balloon model of the alveolus. J Theor Biol (1982) 0.75

Kinetics of calcium-induced fusion of cell-size liposomes with monolayers in solutions of different osmolarity. Z Naturforsch C (1985) 0.75